Curcumin reported to inhibit migration and invasion in GBM in in-vitro studies as well as in in-vivo models of GBM cells through various pathways such as regulation of proteins MMP-2/9, fascin expression, SHH/GLI1 pathway and miRNA51–53. The gene discussed is GLI1; the disease is glioblastoma.